|Bid||44.27 x 3100|
|Ask||44.42 x 1100|
|Day's range||44.29 - 44.92|
|52-week range||37.80 - 46.97|
|Beta (5Y monthly)||0.29|
|PE ratio (TTM)||17.56|
|Earnings date||01 Feb 2017 - 06 Feb 2017|
|Forward dividend & yield||1.99 (4.42%)|
|Ex-dividend date||19 May 2022|
|1y target est||49.81|
Innoviva (INVA) is set to acquire Entasis (ETTX) for $2.20 per share in cash. The transaction is likely to close by third-quarter 2022.
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Berkshire Hathaway Inc. (BRK.B), and S&P Global Inc. (SPGI).